Emcure Pharmaceuticals consolidated net profit rises 42.05% in the June 2026 quarter
(06 Aug 2026)
Back
Net profit of Emcure Pharmaceuticals rose 42.05% to Rs 293.98 crore in the quarter ended June 2026 as against Rs 206.95 crore during the previous quarter ended June 2025. Sales rose 22.85% to Rs 2580.45 crore in the quarter ended June 2026 as against Rs 2100.54 crore during the previous quarter ended June 2025.
| Particulars | Quarter Ended | | Jun. 2026 | Jun. 2025 | % Var. |
| Sales | 2580.45 | 2100.54 | 23 |
| OPM % | 20.64 | 19.84 | - |
| PBDT | 503.03 | 393.71 | 28 |
| PBT | 393.53 | 294.26 | 34 |
| NP | 293.98 | 206.95 | 42 |
|